Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer

Otolaryngol Head Neck Surg. 2003 Feb;128(2):178-84. doi: 10.1067/mhn.2003.74.

Abstract

Objective: The study goal was to evaluate the use of combined positron emission tomography/computed tomography (PET/CT) imaging for localization of recurrent disease in thyroid cancer patients.

Study design and setting: Eight patients with suspected recurrence of thyroid cancer on the basis of elevated serum thyroglobulin or calcitonin levels underwent combined PET/CT imaging on a prototype device. All 8 patients had previously undergone total thyroidectomy and (131)I ablation for thyroid carcinoma. Patients with papillary carcinoma had negative (131)I scans.

Results: Eight patients underwent combined PET/CT scanning. Four (50%) of 8 patients underwent PET/CT indicating recurrence in the head and neck. A total of 11 lesions in these 4 patients were suspicious for recurrence on combined PET/CT imaging. Three patients with 8 lesions suspicious for recurrence on PET/CT underwent surgical removal of disease. All 3 patients had pathologic confirmation of recurrence, with 6 (75.0%) of 8 lesions being positive.

Conclusion: Combined PET/CT imaging is a valuable tool for the diagnosis and anatomic localization of recurrent thyroid cancer.

MeSH terms

  • Adult
  • Aged
  • Calcitonin / blood
  • Carcinoma / diagnosis*
  • Carcinoma / metabolism
  • Carcinoma / surgery
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Radiopharmaceuticals
  • Sensitivity and Specificity
  • Thyroglobulin / blood
  • Thyroid Neoplasms / diagnosis*
  • Thyroid Neoplasms / metabolism
  • Thyroid Neoplasms / surgery
  • Thyroidectomy
  • Tomography, Emission-Computed*
  • Tomography, X-Ray Computed*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Calcitonin
  • Thyroglobulin